BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//AssetMemo//Readout calendar//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Utreglutide readouts · AssetMemo
X-WR-CALDESC:Upcoming readouts of Utreglutide\, from ClinicalTrials.gov est
 imates.
REFRESH-INTERVAL;VALUE=DURATION:PT12H
X-PUBLISHED-TTL:PT12H
BEGIN:VEVENT
UID:NCT07282743-274@assetmemo.bio
DTSTAMP:20261121T005602Z
DTSTART;VALUE=DATE:20270430
DTEND;VALUE=DATE:20270501
SUMMARY:Utreglutide: Phase 2 readout est. (NCT07282743)
DESCRIPTION:Utreglutide\, phase 2\, Obesity.\nStudy: Efficacy and Safety of
  GL0034 in Overweight or Obese Adults With Type II Diabetes Mellitus\nEsti
 mated primary completion: April 2027. This is a ClinicalTrials.gov estimat
 e\, not a confirmed readout date\, and it can move.\nDrug page: https://as
 setmemo.bio/drug/utreglutide#upcoming-events\nRegistry record: https://cli
 nicaltrials.gov/study/NCT07282743
URL:https://assetmemo.bio/drug/utreglutide#upcoming-events
TRANSP:TRANSPARENT
END:VEVENT
END:VCALENDAR
